Редакционная политика
Тематика журнала
Anti-Cancer Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of anti-cancer agents. Each issue contains a series of timely in-depth/mini-reviews and guest-edited issues written by leaders in the field covering a range of current topics in oncology and medicinal chemistry. The journal considers high-quality reviews and research papers for publication. Scientific areas within the scope of the journal include:
● Medicinal chemistry, prevention, diagnosis, and treatment of malignant diseases
● In silico studies of drug-target interaction in anti-cancer drug assessment
● Underlying biology and medicinal chemistry strategies for anti-cancer drug synthesis and development
● New drugs related to a specific target or target class for anticancer drugs
● Drug repositioning in cancer
● Clinical cancer research
● Radiotherapy and systemic treatment of cancer
● Other related areas
Special Issues devoted to crucial topics, providing the latest comprehensive information on cutting-edge areas of research and technological advances, are welcome.
Anti-Cancer Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in cancer drug discovery.
Разделы и направления
Oncology
Рецензирование
Bentham Science Publishers follows the double-blind peer review procedure for submissions of all manuscripts to its journals.
All submitted articles are subjected to an extensive peer review in consultation with members of the journal’s editorial board and independent external referees (usually three reviewers). All manuscripts/chapters are assessed rapidly and the decision based on all the peer reviewers' comments, taken by the journal’s Editor-in-Chief, is then conveyed to the author(s).
Submissions from the Editor-in-Chief/Co-Editor/Editorial Board Members will undergo independent peer review and will be submitted to another Editor for his decision on acceptance. For further details, please visit complete guidelines at: https://benthamscience.com/pages/peer-reviews
Use of Generative AI and AI-assisted Technologies in the Peer Review Process
Since the use of AI technology has increased, it has brought its own challenges regarding the originality of the review of submitted manuscripts. Bentham Science has been striving to improve its policies accordingly. With time, we will continue to update our policies to support our reviewers, authors, and editors.
The quality of the peer review of submitted articles has been our top priority. The reviewers are advised not to use AI technologies or any other related assisting resources to generate review reports that could compromise the integrity and confidentiality of the reports.
The full Reviewer Guidelines are available here: https://www.benthamscience.com/journal/1/guideline-for-reviewers